DR. GLODERM TABRX LIFTUP

Manufacturer
DR.GLODERM | SAMSUNG MEDICOS. CO., LTD. Hyangnam Factory
Effective date
2017-03-28
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:17:18

Label at a glance#

ProductDR. GLODERM TABRX LIFTUP
Active ingredientADENOSINE, NIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Niacinamide, Adenosine

INACTIVE INGREDIENT SECTION

Water, Glycerin, Butylene Glycol, Hydrogenated Lecithin, Sodium DNA, Centella Asiatica Extract, Ceramide 3, etc.

OTC - PURPOSE SECTION

Skin Protectant - Whitening, Anti-Wrinkle

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

It's melting on the pam taken two capsules with spatula at the last stage of skin care, and apply on the entire face.

Gently pat to help absorption into the skin.

* Do not eat capsules.

WARNINGS SECTION

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).

1) Occurrence of red spots, swelling, itchiness, and other skin irritation

2) If the symptoms above occur after the application area is exposed to direct sunlight

2. Do not use on open wounds, eczema, and other skin irritations

3. Precaution for Storage and Handling

1) Close the lid after use

2) Keep out of reach of infants and children

3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

DOSAGE & ADMINISTRATION SECTION

for external use only


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
QR code linkQR Codem.code.daum.net/mobile/view?vid=xa1rLABEL.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71342-0010-12025-05-14C16284748780-19d75b9d0-8185-f424-e053-dadaa90a57ceDrug Facts
71342-0010-22025-05-14C16284748780-19d75b9d0-8185-f424-e053-dadaa90a57ceDrug Facts
71342-0010-12020-01-31C16284748780-19d75b9d0-8185-f424-e053-dadaa90a57ceDrug Facts
71342-0010-22020-01-31C16284748780-19d75b9d0-8185-f424-e053-dadaa90a57ceDrug Facts

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71342-001071342-0010-1, 71342-0010-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
GLYCERINPDC6A3C0OXIACT
ADENOSINEK72T3FS567ACTIB
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3514eb9c-5551-1676-e063-6294a90afd8b4b6fc08f-c6c8-01cf-e054-00144ff8d46c2025-05-14WarningsExact identifier
spl set id: 4b6fc08f-c6c8-01cf-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.